The CRUK Convergence Science Centre supports a wide variety of research spanning from: early-stage discovery research, which aims to further our understanding of the fundamentals behind cancer; projects relating to detection and diagnosis of cancer; to research that will lead to new ways to treat or monitor the efficacy of cancer treatments in patients. 

 

Across this broad spectrum, the Centre is guided by two overarching research themes, supported by two underpinning initiatives.  

 

 

Our research themes 

 

  • Convergence Discovery Research: which focuses on enhancing our understanding of cancer biology through the identification and exploitation of cancer vulnerabilities and translating these findings into patient benefit through transformative, proof-of-concept, investigator-initiated clinical trials. 

  • Interventional Science: aims to put the patient at the centre of developing technological and methodological innovations and deliver improvements in early detection, diagnosis, therapies (including surgery and radiotherapy) and treatment monitoring. 

 

 

 

Our underpinning initiatives

 

  • Clinical Drug Development: aims to implement new methodologies into clinical research using iterative and reverse translation to create a true synergy between discovery research and clinical trials. 

     

  • Data Science and Digital Pathology: aims to advance capabilities with using multi-modal data and big data sets to improve the integration of knowledge and implement these innovations into discovery research and clinical practice 

 

 

 

 

 

 

Accessibility Cookie policy Privacy policy